BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33512635)

  • 1. PKM2 promotes cell metastasis and inhibits autophagy via the JAK/STAT3 pathway in hepatocellular carcinoma.
    Yu Z; Wang D; Tang Y
    Mol Cell Biochem; 2021 May; 476(5):2001-2010. PubMed ID: 33512635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
    Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00346 promotes hepatocellular carcinoma progression via activating the JAK-STAT3 signaling pathway.
    Yin YZ; Zheng WH; Zhang X; Chen YH; Tuo YH
    J Cell Biochem; 2020 Jan; 121(1):735-742. PubMed ID: 31478228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway.
    Zhang XP; Jiang YB; Zhong CQ; Ma N; Zhang EB; Zhang F; Li JJ; Deng YZ; Wang K; Xie D; Cheng SQ
    Cell Physiol Biochem; 2018; 47(4):1643-1654. PubMed ID: 29945155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway.
    Cui C; Fu K; Yang L; Wu S; Cen Z; Meng X; Huang Q; Xie Z
    J Exp Clin Cancer Res; 2019 May; 38(1):229. PubMed ID: 31142329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.
    Song L; Zhang W; Chang Z; Pan Y; Zong H; Fan Q; Wang L
    Med Sci Monit; 2017 Apr; 23():1741-1750. PubMed ID: 28394882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.
    Zhou Q; Yin Y; Yu M; Gao D; Sun J; Yang Z; Weng J; Chen W; Atyah M; Shen Y; Ye Q; Li CW; Hung MC; Dong Q; Zhou C; Ren N
    Redox Biol; 2022 Oct; 56():102458. PubMed ID: 36116159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
    Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
    Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop.
    Bie C; Chen Y; Tang H; Li Q; Zhong L; Peng X; Shi Y; Lin J; Lai J; Wu S; Tang S
    Dig Dis Sci; 2022 Feb; 67(2):569-584. PubMed ID: 33559791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.
    Kondo R; Ishino K; Wada R; Takata H; Peng WX; Kudo M; Kure S; Kaneya Y; Taniai N; Yoshida H; Naito Z
    Int J Oncol; 2019 Apr; 54(4):1409-1421. PubMed ID: 30720090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.
    Wang Q; Lu D; Fan L; Li Y; Liu Y; Yu H; Wang H; Liu J; Sun G
    Int J Mol Med; 2019 Jan; 43(1):475-488. PubMed ID: 30365092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
    Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO
    PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro.
    Wilson GS; Tian A; Hebbard L; Duan W; George J; Li X; Qiao L
    Cancer Lett; 2013 Dec; 341(2):224-30. PubMed ID: 23941832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions.
    Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y
    World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma.
    Wang L; Li H; Zhen Z; Ma X; Yu W; Zeng H; Li L
    Gene; 2019 Mar; 690():129-136. PubMed ID: 30597237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.